NL7614191A - Werkwijze voor de bereiding van amide- en alkyl- ester-derivaten van pyrimido-(4,5-b)- chinolin-4(3h)-on-2-carbonzuren en zouten daarvan, werkwijze voor de bereiding van preparaten voor de behandeling van maagzweren die deze verbindingen bevatten, alsmede gevormde preparaten verkregen volgens deze werkwijze. - Google Patents

Werkwijze voor de bereiding van amide- en alkyl- ester-derivaten van pyrimido-(4,5-b)- chinolin-4(3h)-on-2-carbonzuren en zouten daarvan, werkwijze voor de bereiding van preparaten voor de behandeling van maagzweren die deze verbindingen bevatten, alsmede gevormde preparaten verkregen volgens deze werkwijze.

Info

Publication number
NL7614191A
NL7614191A NL7614191A NL7614191A NL7614191A NL 7614191 A NL7614191 A NL 7614191A NL 7614191 A NL7614191 A NL 7614191A NL 7614191 A NL7614191 A NL 7614191A NL 7614191 A NL7614191 A NL 7614191A
Authority
NL
Netherlands
Prior art keywords
preparation
preparations
qinolin
pyrimido
amide
Prior art date
Application number
NL7614191A
Other languages
English (en)
Other versions
NL168515B (nl
NL168515C (nl
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NL7614191A publication Critical patent/NL7614191A/nl
Publication of NL168515B publication Critical patent/NL168515B/nl
Application granted granted Critical
Publication of NL168515C publication Critical patent/NL168515C/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NLAANVRAGE7614191,A 1976-01-20 1976-12-21 Werkwijze ter bereiding van derivaten van pyrimido-Ÿ4.5-bŸ-chinolin-4(3h)-on-2-carbonzuren en werkwijze ter bereiding van deze verbindingen bevattende preparaten met anti-ulcer-werking. NL168515C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/650,714 US4011324A (en) 1976-01-20 1976-01-20 Esters and amides of pyrimido[4,5-b]quinolin-4(3H)-one-2-carboxylic acids as antiulcer agents

Publications (3)

Publication Number Publication Date
NL7614191A true NL7614191A (nl) 1977-07-22
NL168515B NL168515B (nl) 1981-11-16
NL168515C NL168515C (nl) 1982-04-16

Family

ID=24609991

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7614191,A NL168515C (nl) 1976-01-20 1976-12-21 Werkwijze ter bereiding van derivaten van pyrimido-Ÿ4.5-bŸ-chinolin-4(3h)-on-2-carbonzuren en werkwijze ter bereiding van deze verbindingen bevattende preparaten met anti-ulcer-werking.

Country Status (10)

Country Link
US (1) US4011324A (nl)
JP (2) JPS5289700A (nl)
BE (1) BE849647A (nl)
DE (1) DE2700216A1 (nl)
DK (1) DK575776A (nl)
FR (1) FR2361892A1 (nl)
GB (1) GB1531681A (nl)
IE (1) IE43964B1 (nl)
LU (1) LU76457A1 (nl)
NL (1) NL168515C (nl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2757915A1 (de) * 1976-12-28 1978-07-06 Mitsubishi Yuka Pharma Pyrimidochinoxalinderivate, verfahren zur herstellung derselben und arzneimittel zur behandlung von allergischem asthma
DE3138550A1 (de) * 1981-09-28 1983-04-07 Boehringer Ingelheim KG, 6507 Ingelheim Substituierte 2-phenyl-2-(pyridyloxy)-ethylamine und isostere verbindungen, verfahren zu ihrer herstellung und verwendung
US4551460A (en) * 1982-05-10 1985-11-05 Hoffmann-La Roche Inc. Pyrido[2,1-b]quinazoline derivatives useful as agents for treatment of allergic conditions and vascular disorders involving thrombosis
DE3232620A1 (de) * 1982-09-02 1984-03-08 Hoechst Ag, 6230 Frankfurt 10-phenyl1-1,3,9-triazaanthracene und diese enthaltendes photopolymerisierbares gemisch
US6545004B1 (en) * 1999-10-27 2003-04-08 Cytokinetics, Inc. Methods and compositions utilizing quinazolinones
US7230000B1 (en) 1999-10-27 2007-06-12 Cytokinetics, Incorporated Methods and compositions utilizing quinazolinones
JPWO2002094790A1 (ja) * 2001-05-23 2004-09-09 三菱ウェルファーマ株式会社 縮合ヘテロ環化合物およびその医薬用途
ITMI20012060A1 (it) * 2001-10-05 2003-04-05 Recordati Chem Pharm Nuovi eterocilcli n-acilati
WO2003070701A2 (en) * 2002-02-15 2003-08-28 Cytokinetics, Inc. Syntheses of quinazolinones
CA2485148A1 (en) * 2002-05-09 2003-11-20 Cytokinetics, Inc. Pyrimidinone compounds, compositions and methods
US7214800B2 (en) * 2002-05-09 2007-05-08 Cytokinetics, Inc. Compounds, compositions, and methods
EP1513820A4 (en) * 2002-05-23 2006-09-13 Cytokinetics Inc COMPOUNDS, COMPOSITIONS AND METHODS
WO2003106426A1 (en) * 2002-06-14 2003-12-24 Cytokinetics, Inc. Compounds, compositions, and methods
AU2003256805A1 (en) * 2002-07-23 2004-02-09 Cytokinetics, Inc. Compounds compositions and methods
US20040048853A1 (en) * 2002-08-21 2004-03-11 Gustave Bergnes Compounds, compositions, and methods
WO2004034972A2 (en) * 2002-09-30 2004-04-29 Cytokinetics, Inc. Compounds, compositions, and methods
JP2007510652A (ja) * 2003-11-03 2007-04-26 サイトキネティクス・インコーポレーテッド ピリミジン−４−オン化合物、組成物、および方法
EP1680420A4 (en) * 2003-11-07 2008-09-24 Cytokinetics Inc COMPOUNDS, COMPOSITIONS AND METHODS
EP1692112A4 (en) * 2003-12-08 2008-09-24 Cytokinetics Inc COMPOUNDS, COMPOSITIONS, AND METHODS
BRPI0510305A (pt) * 2004-04-30 2007-10-02 Takeda Pharmaceutical composto ou um sal do mesmo, pródroga ou um sal da mesma, agente farmacêutico, método de produção do composto ou um sal do mesmo, inibidor de metaloproteinase de matriz ou um sal do mesmo ou uma pródroga do mesmo, método de inibir uma metaloproteinase de matriz, e, uso de um composto ou de um sal do mesmo ou de uma pródroga do mesmo

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3414574A (en) * 1967-04-21 1968-12-03 Sandoz Ag Certain pyrimido (4, 5-b) indoles and intermediates employed in their preparation
US3974161A (en) * 1974-02-20 1976-08-10 Pfizer Inc. Fused pyrimidin-4(3H)-ones as antiallergy agents
GB1458205A (en) * 1973-04-13 1976-12-08 Pfizer Fused pyrimidin-4- 3h-ones as antiallergy agents

Also Published As

Publication number Publication date
FR2361892B1 (nl) 1980-09-19
IE43964L (en) 1977-07-20
JPS5289700A (en) 1977-07-27
GB1531681A (en) 1978-11-08
IE43964B1 (en) 1981-07-15
FR2361892A1 (fr) 1978-03-17
DE2700216A1 (de) 1977-07-28
JPS5470433A (en) 1979-06-06
BE849647A (fr) 1977-06-20
NL168515B (nl) 1981-11-16
US4011324A (en) 1977-03-08
NL168515C (nl) 1982-04-16
LU76457A1 (nl) 1977-07-05
DK575776A (da) 1977-07-21

Similar Documents

Publication Publication Date Title
NL7614191A (nl) Werkwijze voor de bereiding van amide- en alkyl- ester-derivaten van pyrimido-(4,5-b)- chinolin-4(3h)-on-2-carbonzuren en zouten daarvan, werkwijze voor de bereiding van preparaten voor de behandeling van maagzweren die deze verbindingen bevatten, alsmede gevormde preparaten verkregen volgens deze werkwijze.
NL7603340A (nl) Werkwijze voor de continue bereiding van zeer zuiver tereftaalzuur.
NL7604963A (nl) Werkwijze voor de bereiding van koolzuur- houdend snoep.
NL7601116A (nl) Werkwijze voor de bereiding van olefinische derivaten van aminozuren.
NL186905C (nl) Werkwijze voor de continue bereiding van tereftaalzuur.
NL7804587A (nl) Werkwijze voor de bereiding van kristallijne peroxy- carbonzuren.
NL7701342A (nl) Werkwijze voor de bereiding van alkoholen door rechtstreekse hydrogenering van zuren.
NL182217C (nl) Werkwijze voor de bereiding van 2-oxo-3-arylpropionzuur.
NL7604129A (nl) Werkwijze voor de bereiding van hydroxycarbon- zuren en derivaten ervan.
FR2304597A1 (fr) Procede de preparation d'acides carboxyliques insatures
NL7712281A (nl) Werkwijze voor de bereiding van carbonzuren.
NL7700446A (nl) Werkwijze voor de bereiding van zouten van 3.3-dimethyl-2-oxoboterzuur.
NL7710689A (nl) Werkwijze voor de bereiding van carbonzuur- esters.
BE843199A (fr) Procede de preparation de 2,4-dioxo-1,2,3,4-tetrahydro-s-triazino-(1,2-a)-benzimidazoles
NL7705380A (nl) Werkwijze voor de bereiding van onverzadigde carbonzuren.
NL7708091A (nl) Werkwijze voor de bereiding van fenoxy-fenoxy- -alkaancarbonzuurderivaten.
FR2299869A1 (fr) Procede de preparation d'acides (
NL184516C (nl) Werkwijze voor de bereiding van zouten van pyrodruivenzuur.
NL7904056A (nl) Werkwijze voor de bereiding van arylazijnzuurderivaten.
NL7703369A (nl) Werkwijze voor de bereiding van zeer zuiver kristallijn chenodesoxycholzuur.
NL7511338A (nl) Werkwijze voor de bereiding van 4-oxo-4h-pyrano- -(3,2-c)-chinoline-2 carbonzuren en zouten daar- van.
NL7700814A (nl) Werkwijze voor de bereiding van zeer zuiver tereftaalzuur.
NL7610166A (nl) Werkwijze voor de bereiding van zure microbi- ciden.
NL7603816A (nl) Werkwijze voor de bereiding van aminozuren.
NL7704917A (nl) Werkwijze voor de bereiding van 5-fenylcarba- moylbarbituurzuren.

Legal Events

Date Code Title Description
V2 Lapsed due to non-payment of the last due maintenance fee for the patent application